Privium Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$581K Hold
2025
Q2
$610K Hold
2025
Q1
$630K Hold
2024
Q4
$804K Buy
2024
Q3
$514K Buy
2024
Q2
$372K Buy